berberine has been researched along with MS (Multiple Sclerosis) in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine is an alkaloid found in some medicinal plants with anti-inflammatory effects." | 5.91 | Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells. ( Haghmorad, D; Sadighimoghaddam, B; Sameni, HR; Soltanmohammadi, A; Tavaf, MJ; Yazdanpanah, E; Yousefi, B; Zargarani, S, 2023) |
| "Berberine (BBR) has shown neuroprotective properties." | 5.46 | The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway. ( Chen, R; Jiang, G; Luo, J; Qin, X; Wang, L; Yu, J; Zeng, S, 2017) |
| "Berberine is an alkaloid found in some medicinal plants with anti-inflammatory effects." | 1.91 | Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells. ( Haghmorad, D; Sadighimoghaddam, B; Sameni, HR; Soltanmohammadi, A; Tavaf, MJ; Yazdanpanah, E; Yousefi, B; Zargarani, S, 2023) |
| "Berberine (BBR) has shown neuroprotective properties." | 1.46 | The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway. ( Chen, R; Jiang, G; Luo, J; Qin, X; Wang, L; Yu, J; Zeng, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tavaf, MJ | 1 |
| Soltanmohammadi, A | 1 |
| Zargarani, S | 1 |
| Yazdanpanah, E | 1 |
| Sadighimoghaddam, B | 1 |
| Yousefi, B | 1 |
| Sameni, HR | 1 |
| Haghmorad, D | 1 |
| Luo, J | 1 |
| Chen, R | 1 |
| Zeng, S | 1 |
| Yu, J | 1 |
| Jiang, G | 1 |
| Wang, L | 1 |
| Qin, X | 1 |
2 other studies available for berberine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Cytokines; Encephalomyelitis, Autoimmune, Experimental | 2023 |
The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway.
Topics: Animals; Berberine; Encephalomyelitis, Autoimmune, Experimental; Female; Lysophospholipids; Mice; Mi | 2017 |